Inflammatory biomarker analysis confirms reduced disease severity in heterozygous patients with familial Mediterranean fever

Inflammatory biomarker analysis confirms reduced disease severity in heterozygous patients with familial Mediterranean fever

Introduction Familial Mediterranean fever (FMF) is a genetic disease leading to recurrent episodes of inflammation. Two pathogenic variants are required for classical disease, but the disease can occur in heterozygous patients. Patients are treated continuously with colchicine to prevent amyloid A (...

Full description

Bibliographic Details
Main Authors: Elke Lainka, Dirk Foell, Veronique Hentgen, Tilmann Kallinich, Alexandre Belot, Tim Niehues, Gerd Horneff, Caroline Vinit, Helmut Wittkowski, Jens Klotsche, Gayane Amaryan, Frank Dressler, Johannes-Peter Haas, Elisabeth Weissbarth-Riedel, Christoph Rietschel, Rainer Berendes, Prasad Oommen, Claas Hinze, Inès Elhani, Stefan Backes, Sabrina Fühner, Arnd Giese, Anna Lisa Hitzegrad, Annette Jansson, Katerina Theodoropoulo
Format: Article
Language:English
Published: BMJ Publishing Group 2024-12-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/10/4/e004677.full

Internet

https://rmdopen.bmj.com/content/10/4/e004677.full

Similar Items